Dr. Garassino Discusses Recent Pivotal Immunotherapy Findings in NSCLC – OncLive
OncLive |
Dr. Garassino Discusses Recent Pivotal Immunotherapy Findings in NSCLC
OncLive Marina Chiara Garassino, MD, medical consultant, Medical Oncology Division, Fondazione IRCCS Istituto Nazionale dei Tumori, discusses some of the recent exciting results regarding immunotherapy in non–small cell lung cancer (NSCLC). In the last 3 … |
